Skip to main content
. 2003 Jul 2;139(5):973–981. doi: 10.1038/sj.bjp.0705314

Figure 5.

Figure 5

Effects of the treatment with the protein synthesis inhibitors dexamethasone (panel a, 0.5 mg kg−1, s.c., 6 h) and cycloheximide (panel b, 1.5 mg kg−1, s.c., 6 h) or NF-κB activation inhibitors PDTC (panel c, 100 mg kg−1, i.p., 30 min) and TLCK (panel d, 2 mg kg−1, i.p., 30 min) on des-Arg9-BK-induced paw oedema (100 nmol paw−1) in animals pre-treated with PAF (10 nmol paw−1). Each point represents the mean±s.e.m. of four to six animals. In some cases, error bars are hidden within the symbols. Significantly different from control values *P<0.05, **P<0.01.